17V.F VENTURE LIFE GRP LS -003

Consumer Defensive Pharmaceuticals Frankfurt Exchange
0.8000 EUR
Close of Nov 11, 2026
0.6000 0.8200
Market cap
EUR 95.1M
P/E
-
P/B
1.06x
ROE
-0.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2024.

Is 17V.F undervalued?

Graham number

The Graham number of VENTURE LIFE GRP LS -003 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

VENTURE LIFE GRP LS -003 fundamental analysis

No fundamental analysis for VENTURE LIFE GRP LS -003 yet.

VENTURE LIFE GRP LS -003 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About VENTURE LIFE GRP LS -003

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ name. It also provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos; and Glucogel for the treatm…

Full company profile